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Introduction: 
Glutamine synthetase (GS) in brain is predominantly localized in the astrocytes and plays a major role in the detoxification of brain ammonia by 
converting ammonia and glutamate (Glu) in glutamine (Gln). In addition, some de novo synthesis of Glu from glucose is required to maintain the 
neurotransmitter pool. Glutamate-dehydrogenase (GDH), along with aspartate aminotransferase, is an enzyme involved in the homeostasis of the 
brain Glu concentration. 15N MRS is an alternative approach to 13C MRS in studying glutamate-glutamine metabolism and can provide a more 
straightforward interpretation. Previous 15N MRS studies focused on the incorporation of 15N of ammonia into [5-15N]Gln and measured the apparent 
glutamine synthetase activity (Vsyn) (1-4). The incorporation of 15N into [2-15N]Gln+Glu may provide further insight into the net glutamate 
dehydrogenase activity (VGDH). Therefore, for the present study we developed a new pulse sequence in order to simultaneously measure [5-15N]Gln 
and [2-15N]Gln+Glu for a direct measurement of the net glutamine synthesis rate (Vsyn-Vnt), Vsyn and VGDH under 15N-labeled ammonia infusion in 
the rat brain, using in vivo localized 15N MRS interleaved with in vivo 1H MRS. In addition, we performed a direct absolute quantification of total 
Gln, 5-15N Gln and 2-15N Glu+Gln in the same experiment. 
Methods: 
Six SD rats (300-350g) were fasted overnight. The femoral artery and vein were catheterized for blood sampling as well as 15N ammonium chloride 
(99%-enriched) and α-chloralose infusion. 15N ammonium chloride was infused continuously (4.5mmol/h/kg) for up to 9-10h (3,4). All the 1H and 
15N MRS data were acquired interleaved on a 9.4T system (Varian/Magnex Scientific) using a home-built quadrature 1H coil combined with a single 
5-loop 10 mm 15N coil. The 1H spectra were acquired using an ultra-short-TE localized SPECIAL spectroscopy sequence (TE=2.8ms, TR=4s, 128 
scans, VOI=6x8x8mm3) (5). Shimming was performed with FASTMAP. The 15N spectra were acquired using the SIRENE sequence (6). Due to the 
large chemical shift difference between 5-15N Gln and 2-15N Glu+Gln (~70ppm) the two 15N 
signals were acquired separately in an interleaved mode using two adiabatic excitation pulses with 
opposite frequency modulations (Fig. 1). Unlocalized spectra were acquired in the first hours of 
infusion (256 scans, TR=5s), followed by a localized spectrum (VOI=6x8x8mm3, 256 averages) 
used for quantification. 1H spectra were quantified using LCModel. 
The 15N spectra were quantified using AMARES and an external 
reference method (7). The metabolic model used is shown on Fig 1. 
A neuroglial two-compartment model, assuming negligible efflux 
from the Gln pool compared to Vsyn (1), was fitted simultaneously 
to the total Gln, 5-15N Gln and 2-15N Glu+Gln curves and values for 
(Vsyn-Vnt), Vsyn and VGDH were obtained. 
Results and Discussion:  
Fig. 3 shows a series of in vivo unlocalized 15N spectra acquired in the rat brain during infusion. The 5-15N Gln peak (-271ppm) was visible in the 
first and all subsequent scans, whereas the 2-15N Gln+Glu peak (-342ppm) started to appear from the second scan. Compared with the one RF 
excitation SIRENE sequence, the new pulse sequence using the 2 adiabatic RF excitation pulses allowed the detection of 2-15N Gln+Glu peak approx 
50 min earlier due to a better excitation and an increased SNR. The initial total Gln (0) concentration was 2.5±0.3 mmol/kgww and increased to 
17.7±1.4mmol/kgww at the end of the infusion, which was in the range of previous biochemical studies (1-3). All other metabolites remained 
unchanged during the experiment. The time courses of total Gln, 5-15N Gln and 2-15N Gln+Glu were highly reproducible in all six rats. The 
application of the model to the in vivo data showed an excellent fit (Fig. 4). Based on the model presented in Fig. 1 we obtained from the 1H data a 
net synthesis flux (Vsyn-Vnt) of 0.035±0.001µmol/min/g. By fitting the in vivo 5-15N Gln and 2-15N Glu+Gln time courses, Vsyn was 
0.24±0.03µmol/min/g, VGDH was 0.030±0.001µmol/min/g and the plasma NH3 FE was 84±6%. Finally, the apparent neurotransmission rate, Vnt, was 
0.21±0.03µmol/min/g.  
In order to maintain a constant Glu concentration with increasing Gln, 
glutamate needs to be synthesized from TCA intermediates or from 
aspartate. Previous studies supposed that this replenishment acts 
primarily on the glial side in hyperammonemic conditions (2). From high 
resolution measurements on brain extracts we obtained (2N-
15NGln)FE/(2N-15NGlu)FE=1.48±0.04, which proves the fact that net 
glutamate synthesis results from higher glial GDH activity. In addition, 
our results also showed that VGDH ≈ (Vsyn-Vnt), meaning that VGDH is 
the primary source of Glu replenishment. Since Vsyn and Vnt which are 
needed to model the exchange between 2N-15N Glu and 2N-15N Gln are 
obtained from the simultaneous fit, 2-15N Gln+Glu is sufficient for the 
measurement of VGDH. We conclude that using this new technique it is 
feasible to combine localized in vivo 15N with 1H MRS for measuring the net glutamine accumulation and VGDH along with Vsyn under ammonia 
infusion in the in vivo rat brain. This technique allows a robust absolute quantification of total Gln, 5-15N Gln and 2-15N Gln+Glu in the same 
experiment. Moreover, in contrast to previous studies, the net synthesis flux (Vsyn-Vnt) and VGDH were directly measured.  
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Fig 1: Evolution of Z magnetization for the 2 
adiabatic RF pulses used in the new pulse 
sequence for exciting separately 5-15N Gln and 2-
15N Glu+Gln.
 
Fig. 3: A series of in vivo unlocalized 
15N spectra acquired at 9.4T in the rat 
brain at different time points for up to 9h. 
Fig. 2: Metabolic model 
Fig. 4: The time courses and 
corresponding fits of total Gln, 5-15N 
Gln and 2-15N Gln+Glu from 1 rat.  
